ASCO 2022 | Future directions for head and neck cancer

Sue S. Yom, MD, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, talks on the importance of in-person congresses for collaboration and discussion, as well as discussing some of the key areas to focus on in head and neck cancer, such as the rise of immunotherapy, improving diversity in clinical trials, and implementing personalised medicine so that patients receive the best care. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.